STOCK TITAN
  1. Home
  2. Sec-filings
  3. VANI
  4. [Form 4] Vivani Medical, Inc. Insider Trading Activity

Insider Gregg Williams boosts Vivani Medical (Nasdaq: VANI) stake with private share buys

Filing Impact
(Very High)
Filing Sentiment
(Positive)
Form Type
4

Rhea-AI Filing Summary

Vivani Medical, Inc. director and 10% owner Gregg Williams reported additional insider purchases of the company’s common stock. On January 15, 2026, he reported the purchase of 1,473,214 shares at $1.12 per share under a private sale tied to a March 26, 2025 share purchase agreement, with gross proceeds of $1,649,999.68. He also reported purchasing 264,551 shares at $1.26 per share through a separate private sale under an August 11, 2025 share purchase agreement, with gross proceeds of $333,334.26.

After these transactions, Williams is reported as beneficially owning a total of 31,363,309 shares of Vivani Medical common stock. This includes 4,799,200 shares held directly and additional shares held through the Gregg G. Williams 2006 Trust, Williams International Co. LLC, Sam Williams Family Investments LLC, and the Sam B. Williams 1995 Generation-Skipping Trust, over which he has voting and dispositive power.

Positive

  • None.

Negative

  • None.
Insider Williams Gregg
Role Director, 10% Owner
Bought 1,737,765 shs ($1.98M)
Type Security Shares Price Value
Purchase Common Stock 1,473,214 $1.12 $1.65M
Purchase Common Stock 264,551 $1.26 $333K
holding Common Stock -- -- --
Holdings After Transaction: Common Stock — 26,299,558 shares (Indirect, See footnote); Common Stock — 4,799,200 shares (Direct)
Footnotes (1)
  1. The reporting person purchased 1,473,214 shares of the Issuer's common stock in a private sale transaction as disclosed in the Share Purchase Agreement dated as of March 26, 2025 at a price of $1.12 per share, which was the last reported sale price of the Issuers common stock on the Nasdaq on March 25, 2025 (the day immediately prior to March 26, 2025). The gross proceeds from this private sale transaction were $1,649,999.68. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in the transaction set forth in this footnote. The reporting person purchased 264,551 shares of the Issuer's common stock in a private sale transaction as disclosed in the Share Purchase Agreement dated as of August 11, 2025 at a price of $1.26 per share, which was the last reported sale price of the Issuer's common stock on the Nasdaq on August 10, 2025 (the day immediately prior to August 11, 2025). The gross proceeds from this private sale transaction were $333,334.26. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in the transaction set forth in this footnote. The reporting person owns 31,363,309 shares directly and/or indirectly as follows: (i) 4,799,200 shares of common stock owned by the reporting person, (ii) 24,438,357 shares of common stock owned by Gregg G. Williams 2006 Trust, (iii) 1,212,856 shares of common stock owned by Williams International Co. LLC, (iv) 181,587 shares of common stock owned by Sam Williams Family Investments LLC, and (v) 731,309 shares of common stock owned by Sam B. Williams 1995 Generation-Skipping Trust. Gregg Williams has voting and dispositive power over all of these shares.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Williams Gregg
(Last) (First) (Middle)
C/O VIVANI MEDICAL, INC.
1350 S. LOOP ROAD
(Street)
ALAMEDA CA 94502
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Vivani Medical, Inc. [ VANI ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director X 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
01/15/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 01/15/2026 P(1) 1,473,214 A $1.12 26,299,558 I See footnote(3)
Common Stock 01/15/2026 P(2) 264,551 A $1.26 26,564,109 I See footnote(3)
Common Stock 4,799,200 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The reporting person purchased 1,473,214 shares of the Issuer's common stock in a private sale transaction as disclosed in the Share Purchase Agreement dated as of March 26, 2025 at a price of $1.12 per share, which was the last reported sale price of the Issuers common stock on the Nasdaq on March 25, 2025 (the day immediately prior to March 26, 2025). The gross proceeds from this private sale transaction were $1,649,999.68. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in the transaction set forth in this footnote.
2. The reporting person purchased 264,551 shares of the Issuer's common stock in a private sale transaction as disclosed in the Share Purchase Agreement dated as of August 11, 2025 at a price of $1.26 per share, which was the last reported sale price of the Issuer's common stock on the Nasdaq on August 10, 2025 (the day immediately prior to August 11, 2025). The gross proceeds from this private sale transaction were $333,334.26. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in the transaction set forth in this footnote.
3. The reporting person owns 31,363,309 shares directly and/or indirectly as follows: (i) 4,799,200 shares of common stock owned by the reporting person, (ii) 24,438,357 shares of common stock owned by Gregg G. Williams 2006 Trust, (iii) 1,212,856 shares of common stock owned by Williams International Co. LLC, (iv) 181,587 shares of common stock owned by Sam Williams Family Investments LLC, and (v) 731,309 shares of common stock owned by Sam B. Williams 1995 Generation-Skipping Trust. Gregg Williams has voting and dispositive power over all of these shares.
/s/ Anthony Baldor, Attorney-in-fact 01/20/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What insider transactions did Gregg Williams report for Vivani Medical (VANI)?

Gregg Williams reported two insider purchases of Vivani Medical common stock dated January 15, 2026. He acquired 1,473,214 shares at $1.12 per share and 264,551 shares at $1.26 per share, both through private sale transactions disclosed in prior share purchase agreements.

How many Vivani Medical (VANI) shares did Gregg Williams buy in the private transactions?

According to the filing, Gregg Williams purchased 1,473,214 shares of Vivani Medical common stock at $1.12 per share and an additional 264,551 shares at $1.26 per share, all in privately negotiated sale transactions.

What were the gross proceeds of the reported Vivani Medical (VANI) private share sales?

The filing states that the private sale involving 1,473,214 shares at $1.12 per share had gross proceeds of $1,649,999.68, and the sale involving 264,551 shares at $1.26 per share had gross proceeds of $333,334.26.

How many Vivani Medical (VANI) shares does Gregg Williams beneficially own after these transactions?

After the reported transactions, Gregg Williams is reported as beneficially owning 31,363,309 shares of Vivani Medical common stock. This includes 4,799,200 shares owned directly and additional shares held through various trusts and LLCs over which he has voting and dispositive power.

How are Gregg Williams’ Vivani Medical (VANI) holdings structured between direct and indirect ownership?

The filing explains that Gregg Williams holds 4,799,200 shares directly. Indirect holdings include 24,438,357 shares owned by the Gregg G. Williams 2006 Trust, 1,212,856 shares owned by Williams International Co. LLC, 181,587 shares owned by Sam Williams Family Investments LLC, and 731,309 shares owned by the Sam B. Williams 1995 Generation-Skipping Trust, all subject to his voting and dispositive power.

What is Gregg Williams’ role at Vivani Medical (VANI) as noted in the filing?

The filing identifies Gregg Williams as both a director and a 10% owner of Vivani Medical, Inc.